Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear decrease » linear increase (Expand Search)
year increase » linear increase (Expand Search), may increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear decrease » linear increase (Expand Search)
year increase » linear increase (Expand Search), may increase (Expand Search)
-
21121
Table 1_Nonlinear association of a composite metabolic index (ZJU index) with hypertension: a cross-sectional study of NHANES 2003–2018.docx
Published 2025“…Participants with higher ZJU index values had significantly increased risk compared to the reference group (OR = 3.73; 95% CI: 3.25–4.29). …”
-
21122
Data associated with manuscript 'Enhanced encephalitic tropism of bovine H5N1 compared to the Vietnam H5N1 isolate in mice'
Published 2025“…<p dir="ltr">In recent years, the landscape of highly pathogenic avian influenza (HPAI) virus infections has shifted, as evidenced by an increase in infections among mammals. …”
-
21123
Supplementary Material for: Clopidogrel Use in Saudi Arabia: Prescription Patterns and Prevalence of Common Concurrent Medications
Published 2025“…This study found that 32.05% of patients co-used statins, 28.61% used PPIs, and 22.22% used antiplatelets, highlighting significant risks of DDIs. These interactions may compromise efficacy or increase adverse outcomes, such as bleeding. …”
-
21124
Data Sheet 1_Analysis of the level of polypharmacy in patients from an isolated rural area: effect of age, sex, and chronic diseases.pdf
Published 2025“…Introduction<p>The increase in life expectancy and the greater number of chronic diseases have led to a greater use of medications. …”
-
21125
Effect of induced astigmatism on vestibulo-ocular reflex
Published 2025“…</p> <p>The latencies of N1 and P1 significantly increased with the increasing power of induced astigmatism; however, the powers of astigmatism had no effect on the amplitude of N1-P1. …”
-
21126
Table 1_Methodological panorama of clinical trials for diabetic foot ulcers: a scope review of design, implementation and reporting.xlsx
Published 2025“…</p>Result<p>The study revealed a rapid increase in the number of clinical trials focusing on DFU in recent years. …”
-
21127
Table 1_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.docx
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21128
Data Sheet 2_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.pdf
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21129
Data Sheet 1_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.pdf
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21130
Data Sheet 3_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.pdf
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21131
Data Sheet 5_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.pdf
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21132
Data Sheet 6_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.pdf
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21133
Data Sheet 4_Unveiling the role of stress hyperglycemia in predicting mortality for critically ill hemorrhagic stroke patients: insights from MIMIC-IV.pdf
Published 2025“…Multivariate Cox regression analysis indicated that elevated SHR was independently associated with increased ACM at 30 days (adjusted hazard ratio [aHR]: 1.41; 95% confidence interval [CI]: 1.10–1.81; P = 0.006), 90 days (aHR: 1.33; 95% CI: 1.08–1.65; P = 0.008), and 1 year (aHR: 1.27; 95% CI: 1.05–1.54; P = 0.014). …”
-
21134
DataSheet1_Impact of intraspecific genetic variation on interspecific competition: a theoretical case study of forage binary mixtures.docx
Published 2024“…Introduction<p>Increasing intraspecific genetic variation (IV) has been identified as a potential factor to improve productivity and stabilise botanical composition in plant communities. …”
-
21135
DataSheet1_Impact of intraspecific genetic variation on interspecific competition: a theoretical case study of forage binary mixtures.docx
Published 2024“…Introduction<p>Increasing intraspecific genetic variation (IV) has been identified as a potential factor to improve productivity and stabilise botanical composition in plant communities. …”
-
21136
Table 1_Cost-effectiveness evaluation of benmelstobart, anlotinib and chemotherapy in patients with extensive-stage small-cell lung cancer.xlsx
Published 2025“…</p>Methods<p>Using a Markov model over 5-year boundary and data from the ETER701 trials, we analyzed quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER), total cost, incremental net health benefit (INHB) and incremental monetary benefit (INMB). …”
-
21137
Supplementary Material for: IgA Nephropathy and the Risk of Primary Infections: A Swedish population-based cohort study
Published 2025“…The increased risk of sepsis warrants clinical awareness and prevention.…”
-
21138
Data Sheet 1_Crop-specific response of soil prokaryotic community to long-term intensification management: the importance of crop phase at sampling.pdf
Published 2024“…Nitrogen fertilization had a minor effect (3.12%) and was detected only after maize sampling; cover crops had no significant effect. However, the presence of cover crops showed higher alpha diversity and an increased abundance of Proteobacteria. …”
-
21139
Table 2_Cost-effectiveness evaluation of benmelstobart, anlotinib and chemotherapy in patients with extensive-stage small-cell lung cancer.xlsx
Published 2025“…</p>Methods<p>Using a Markov model over 5-year boundary and data from the ETER701 trials, we analyzed quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER), total cost, incremental net health benefit (INHB) and incremental monetary benefit (INMB). …”
-
21140
Table 3_Cost-effectiveness evaluation of benmelstobart, anlotinib and chemotherapy in patients with extensive-stage small-cell lung cancer.xlsx
Published 2025“…</p>Methods<p>Using a Markov model over 5-year boundary and data from the ETER701 trials, we analyzed quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER), total cost, incremental net health benefit (INHB) and incremental monetary benefit (INMB). …”